ASENSUS SURGICAL INC (ASXC)
US04367G1031 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 17.10M | 6.30M | 18.10M | 16.40M | 9.60M | |||
| Marketable Securities | 3.97M | 64.20M | 80.30M | N/A | 0.00 | |||
| Receivables | 3.51M | 2.80M | 2.10M | 4.00M | 3.30M | |||
| Inventories | 7.17M | 8.30M | 8.60M | 10.00M | 10.70M | |||
| Other Current Assets | 4.64M | 5.30M | 4.30M | 3.60M | 4.40M | |||
| Total Current Assets | 36.39M | 86.90M | 113.30M | 34.00M | 28.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.12M | 14.50M | 16.30M | 11.50M | 7.00M | |||
| Investments And Advances | 0.00 | 3.90M | 37.40M | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | 0.00 | |||
| Intangibles | 1.24M | 1.60M | 9.90M | 22.30M | 31.10M | |||
| Other Non-Current Assets | 7.34M | 9.20M | 9.50M | 10.40M | 8.80M | |||
| Total Non-Current Assets | 22.70M | 29.20M | 73.20M | 44.30M | 46.80M | |||
| TOTAL ASSETS | 59.09M | 116.10M | 186.50M | 78.30M | 74.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 1.20M | N/A | |||
| Accrued Expenses | 8.06M | 6.60M | 5.90M | 6.30M | 8.60M | |||
| Accounts Payable | 4.14M | 3.30M | 3.40M | 2.00M | 3.60M | |||
| Other Current Liabilities | 421.00K | 500.00K | 500.00K | 800.00K | 900.00K | |||
| Total Current Liabilities | 12.63M | 10.40M | 9.90M | 10.30M | 13.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 1.60M | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 1.40M | |||
| Other Non-Current Liabilities | 13.04M | 6.00M | 7.40M | 4.80M | 4.80M | |||
| Total Non-Current Liabilities | 13.04M | 6.00M | 7.30M | 6.40M | 6.20M | |||
| TOTAL LIABILITIES | 25.67M | 16.40M | 17.20M | 16.70M | 19.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -939.37M | -860.90M | -785.40M | -722.90M | -663.60M | |||
| Additional Paid In Capital | 973.13M | 962.70M | 954.60M | 781.40M | 720.50M | |||
| Common Shares | 265.00K | 200.00K | 200.00K | 100.00K | 0.00 | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -612.00K | -2.40M | -300.00K | 3.00M | -1.40M | |||
| Shares Outstanding | 264.92M | 236.90M | 235.20M | 116.20M | 20.70M | |||
| Tangible Book Value per Share | 0.12 | 0.41 | 0.68 | 0.34 | 1.18 | |||
| Total Shareholders' Equity | 33.41M | 99.60M | 169.20M | 61.60M | 55.50M | |||
| TOTAL LIABILITIES AND EQUITY | 59.09M | 116.10M | 186.50M | 78.30M | 74.80M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.03 | N/A | |||
| Current Ratio | 2.88 | 8.36 | 11.44 | 3.30 | 2.15 | |||
| Return On Assets (ROA) | -132.74% | -65.08% | -33.49% | -76.65% | -206.15% | |||
| Return On Equity (ROE) | -234.73% | -75.86% | -36.91% | -97.44% | -277.84% | |||
All data in USD